Innovating Works

OLINK PROTEOMICS AB

Desconocido
PREVALUNG EU: Biomarkers affecting the transition from cardiovascular disease to lung cancer: towards stratified i... OLINK PROTEOMICS AB participó en un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02 Cardiovascular disease (CVD) and lung cancer (LC) are leading causes of deaths and intertwined chronic inflammatory processes associated wit...
2022-11-24 - 2027-11-30 | Financiado
ULTRADIAN: Dynamic hormone diagnostics OLINK PROTEOMICS AB participó en un H2020: H2020-PHC-2014-2015 We propose to revolutionize current endocrine diagnostics by replacing conventional, time-consuming single-analyte hormone assays with ambul...
2015-03-27 - 2020-02-29 | Financiado
IBD-CHARACTER: Inflammatory Bowel Disease CHARACTERization by a multi modal integrated biomarker study OLINK PROTEOMICS AB participó en un FP7: We propose a collaborative effort to advance our understanding of the inflammatory bowel diseases Ulcerative Colitis and Crohn's Disease and...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.